Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0325 Transporter Info | ||||
Gene Name | SLC37A4 | ||||
Transporter Name | Glucose-6-phosphate translocase | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
Estradiol co-treated with Progesterone results in increased expression of SLC37A4 mRNA | [42] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Cisplatin co-treated with jinfukang results in increased expression of SLC37A4 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Valproic Acid results in increased expression of SLC37A4 mRNA | [48] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Benzo(a)pyrene affects the methylation of SLC37A4 promoter | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
2,3-bis(3'-hydroxybenzyl)butyrolactone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of SLC37A4 mRNA | [26] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid results in increased expression of SLC37A4 mRNA | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
abrine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
abrine results in decreased expression of SLC37A4 mRNA | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Acrolein |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone affects the expression of SLC37A4 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which affects the expression of SLC37A4 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
alpha-pinene |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone affects the expression of SLC37A4 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which affects the expression of SLC37A4 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
aristolochic acid I |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
aristolochic acid I results in decreased expression of SLC37A4 mRNA | [30] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
aristolochic acid I results in decreased expression of SLC37A4 protein | [30] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
beta-Naphthoflavone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
beta-Naphthoflavone results in decreased expression of SLC37A4 protein | [33] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A affects the expression of SLC37A4 mRNA | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bufotalin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bufotalin results in decreased expression of SLC37A4 mRNA | [34] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium Chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in increased abundance of Cadmium which results in increased expression of SLC37A4 mRNA | [35] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
CGP 52608 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
CGP 52608 promotes the reaction RORA protein binds to SLC37A4 gene | [36] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
cobaltous chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
cobaltous chloride results in decreased expression of SLC37A4 mRNA | [37] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Copper |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NSC 689534 binds to Copper which results in decreased expression of SLC37A4 mRNA | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Coumestrol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of SLC37A4 mRNA | [26] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Decitabine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Decitabine inhibits the reaction Smoke results in decreased expression of SLC37A4 mRNA | [39] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
di-n-butylphosphoric acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
di-n-butylphosphoric acid affects the expression of SLC37A4 mRNA | [40] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
erucylphospho-N,N,N-trimethylpropylammonium |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
erucylphospho-N,N,N-trimethylpropylammonium results in decreased expression of SLC37A4 mRNA | [41] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
K 7174 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
K 7174 results in decreased expression of SLC37A4 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Manganese |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
manganese chloride results in increased abundance of Manganese which results in increased expression of SLC37A4 mRNA | [31] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
manganese chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
manganese chloride results in increased abundance of Manganese which results in increased expression of SLC37A4 mRNA | [31] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
methacrylaldehyde |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone affects the expression of SLC37A4 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which affects the expression of SLC37A4 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
methyleugenol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
methyleugenol results in decreased expression of SLC37A4 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
methylmercuric chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
methylmercuric chloride results in decreased expression of SLC37A4 mRNA | [43] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
NSC 689534 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NSC 689534 binds to Copper which results in decreased expression of SLC37A4 mRNA | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Okadaic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Okadaic Acid results in decreased expression of SLC37A4 mRNA | [44] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Ozone |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone affects the expression of SLC37A4 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which affects the expression of SLC37A4 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Volatile Organic Compounds co-treated with Ozone affects the expression of SLC37A4 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Progesterone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Estradiol co-treated with Progesterone results in increased expression of SLC37A4 mRNA | [42] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sodium arsenite |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in decreased expression of SLC37A4 mRNA | [46] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
sodium arsenite results in increased abundance of Arsenic which results in decreased expression of SLC37A4 mRNA | [31] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
tert-Butylhydroperoxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tert-Butylhydroperoxide results in decreased expression of SLC37A4 mRNA | [47] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Thiram |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Thiram results in decreased expression of SLC37A4 mRNA | [46] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Nanoparticle |
|||||
perfluoro-n-nonanoic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
perfluoro-n-nonanoic acid results in decreased expression of SLC37A4 mRNA | [45] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Dexamethasone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Dexamethasone increases the expression of SLC37A4 | [1] | |||
Regulation Mechanism |
via enhancement of Glucocorticoid receptor (NR3C1) | Transcription Factor Info | |||
Cell System |
Rat hepatocellular carcinoma cells (H4-II-E) | ||||
Copper Sulfate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Copper Sulfate inhibits the expression of SLC37A4 | [2] | |||
Estradiol |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Estradiol inhibits the expression of SLC37A4 | [3] | |||
Zoledronic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zoledronic Acid increases the expression of SLC37A4 | [4] | |||
Rosiglitazone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Rosiglitazone inhibits the expression of SLC37A4 | [5] | |||
Carbamazepine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Carbamazepine affects the expression of SLC37A4 | [6] | |||
Cisplatin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cisplatin increases the expression of SLC37A4 | [7] | |||
Urethane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Urethane inhibits the expression of SLC37A4 | [8] | |||
Acetaminophen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acetaminophen inhibits the expression of SLC37A4 | [9] | |||
Valproic Acid |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid inhibits the expression of SLC37A4 | [10] | |||
Temozolomide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Temozolomide increases the expression of SLC37A4 | [11] | |||
Ivermectin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Ivermectin inhibits the expression of SLC37A4 | [12] | |||
Tretinoin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tretinoin inhibits the expression of SLC37A4 | [13] | |||
Arsenic Trioxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Arsenic Trioxide increases the expression of SLC37A4 | [14] | |||
Cyclosporine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cyclosporine inhibits the expression of SLC37A4 | [15] | |||
Drug in Phase 3 Trial |
|||||
Curcumin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Curcumin inhibits the expression of SLC37A4 | [16] | |||
Drug in Phase 2 Trial |
|||||
Bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol A affects the expression of SLC37A4 | [21] | |||
Investigative Drug |
|||||
Chlorogenic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Chlorogenic acid inhibits the activity of SLC37A4 | [25] | |||
Patented Pharmaceutical Agent |
|||||
K-7174 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
K-7174 inhibits the expression of SLC37A4 | [18] | |||
GSK-J4 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
GSK-J4 inhibits the expression of SLC37A4 | [20] | |||
Natural Product |
|||||
Methyleugenol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Methyleugenol inhibits the expression of SLC37A4 | [22] | |||
Tobacco Smoke Pollution |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tobacco Smoke Pollution inhibits the expression of SLC37A4 | [24] | |||
Traditional Medicine |
|||||
Jinfukang |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Jinfukang increases the expression of SLC37A4 | [7] | |||
Mycotoxins |
|||||
Aflatoxin B1 |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aflatoxin B1 inhibits the expression of SLC37A4 | [17] | |||
DT Modulation2 |
Aflatoxin B1 affects the expression of SLC37A4 protein | [3] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Acute Toxic Substance |
|||||
Acrylamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrylamide inhibits the expression of SLC37A4 | [23] | |||
Carcinogen |
|||||
Benzo(a)pyrene |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene inhibits the expression of SLC37A4 | [22] | |||
Arsenic |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic which results in decreased expression of SLC37A4 mRNA | [31] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in increased abundance of Cadmium which results in increased expression of SLC37A4 mRNA | [35] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Health and Environmental Toxicant |
|||||
tris(1,3-dichloro-2-propyl)phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of SLC37A4 | [19] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.